News
Javed Shaikh, Director of RWE & HEOR, Axtria, explains how harnessing next-generation sequencing and AI-powered analytics ...
Although scientists said larger clinical trials will be needed, the early results point to a 50-50 chance that this treatment could restore a paralyzed patient's ability to move again.
Here authors show blocking Prox1 accumulation and intercellular transfer from retinal neurons enables MG reprogramming of retinal progenitor cells ... barrier to human iPSC derivation through ...
Additionally, induced pluripotent stem cells (iPSCs) from SCA7 patients were differentiated into ... To quantify nuclear membrane abnormalities in retinal neurons, retinal sections were incubated in ...
Synthego and Vita Therapeutics Announce Strategic Licensing Agreement for hfCas12Max CRISPR Nuclease
Synthego and Vita Therapeutics, Inc. today announced a licensing agreement to integrate Synthego's high-fidelity hfCas12Max CRISPR system into Vita's cell therapeutic programs. This nonexclusive ...
Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like ...
Stem cell therapies hold promise for promoting regeneration. Retinal stem cells (RSCs) possess self-renewal capabilities and ...
More information: Kimberly L. Edwards et al, Robust generation of photoreceptor-dominant retinal organoids from porcine induced pluripotent stem cells, Stem Cell Reports (2025). DOI: 10.1016/j ...
Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that initiate the cascade of events that lead to vision. Damage to the photoreceptors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results